Guerbet Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
David Hale
Chief executive officer
€1.5m
Total compensation
CEO salary percentage | 31.7% |
CEO tenure | 4.9yrs |
CEO ownership | n/a |
Management average tenure | 4.9yrs |
Board average tenure | 7.6yrs |
Recent management updates
Recent updates
Guerbet SA (EPA:GBT) Might Not Be As Mispriced As It Looks After Plunging 29%
Nov 16Is Guerbet (EPA:GBT) Using Too Much Debt?
Apr 27Further Upside For Guerbet SA (EPA:GBT) Shares Could Introduce Price Risks After 48% Bounce
Feb 29Returns On Capital At Guerbet (EPA:GBT) Paint A Concerning Picture
Feb 11Guerbet SA (EPA:GBT) Screens Well But There Might Be A Catch
Jan 15The Returns On Capital At Guerbet (EPA:GBT) Don't Inspire Confidence
Jul 22Guerbet SA's (EPA:GBT) Intrinsic Value Is Potentially 92% Above Its Share Price
Jul 27Analysts Have Been Trimming Their Guerbet SA (EPA:GBT) Price Target After Its Latest Report
Mar 28Is Guerbet (EPA:GBT) A Risky Investment?
Oct 25The Returns On Capital At Guerbet (EPA:GBT) Don't Inspire Confidence
Sep 23Is Now The Time To Look At Buying Guerbet SA (EPA:GBT)?
May 27We Think Guerbet (EPA:GBT) Is Taking Some Risk With Its Debt
May 04Is Guerbet SA (EPA:GBT) A Good Fit For Your Dividend Portfolio?
Apr 05Guerbet SA's (EPA:GBT) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Mar 19What Type Of Shareholders Make Up Guerbet SA's (EPA:GBT) Share Registry?
Mar 01When Should You Buy Guerbet SA (EPA:GBT)?
Feb 10How Much Did Guerbet's(EPA:GBT) Shareholders Earn From Share Price Movements Over The Last Three Years?
Jan 28Guerbet SA (EPA:GBT) Shares Could Be 25% Above Their Intrinsic Value Estimate
Jan 13Would Guerbet SA (EPA:GBT) Be Valuable To Income Investors?
Dec 23We Think Guerbet's (EPA:GBT) Statutory Profit Might Understate Its Earnings Potential
Dec 11Do Its Financials Have Any Role To Play In Driving Guerbet SA's (EPA:GBT) Stock Up Recently?
Nov 27CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Jun 30 2024 | n/a | n/a | €33m |
Mar 31 2024 | n/a | n/a | €28m |
Dec 31 2023 | €1m | €470k | €24m |
Sep 30 2023 | n/a | n/a | -€9m |
Jun 30 2023 | n/a | n/a | -€42m |
Mar 31 2023 | n/a | n/a | -€42m |
Dec 31 2022 | €1m | €470k | -€41m |
Sep 30 2022 | n/a | n/a | -€14m |
Jun 30 2022 | n/a | n/a | €13m |
Mar 31 2022 | n/a | n/a | €23m |
Dec 31 2021 | €2m | €470k | €33m |
Sep 30 2021 | n/a | n/a | €33m |
Jun 30 2021 | n/a | n/a | €33m |
Mar 31 2021 | n/a | n/a | €26m |
Dec 31 2020 | €933k | €470k | €18m |
Compensation vs Market: David's total compensation ($USD1.56M) is above average for companies of similar size in the French market ($USD552.87K).
Compensation vs Earnings: David's compensation has been consistent with company performance over the past year.
CEO
David Hale (56 yo)
4.9yrs
Tenure
€1,481,777
Compensation
Mr. David Hale is Director of Ambu A/S from December 4, 2024. Mr. Hale served as Independent Director of Orpea SA since July 28, 2022 until January 2024. He has been Chief Executive Officer of Guerbet SA s...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO, MD & GM | 4.9yrs | €1.48m | no data | |
Chief Pharmacist | 4.9yrs | €11.50k | no data | |
CFO and Senior VP of Business Development & Licensing | 5.7yrs | no data | no data | |
Senior VP of Technical Operations & Interim Chief Pharmacist | 3.8yrs | no data | no data | |
Director of Legal Affairs | 8.9yrs | no data | no data | |
Senior Vice President of Public Affairs & Corporate Communications | no data | no data | no data | |
Senior Vice President of Human Resources | no data | no data | no data | |
Senior Vice President of Interventional Imaging | 3.9yrs | no data | no data | |
Senior VP of R&D | 7.3yrs | no data | no data | |
Senior Vice President of Diagnostic Imaging | 4.9yrs | no data | no data | |
Senior Vice President of Commercial Operations - Asia-Pacific | 4.9yrs | no data | no data | |
Senior Vice President of Commercial Operations - Americas & EMEA | 4.9yrs | no data | no data |
4.9yrs
Average Tenure
56yo
Average Age
Experienced Management: GBT's management team is considered experienced (4.9 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Honorary Chairman | no data | €18.96k | 54.99% € 173.3m | |
Chairman of the Board | less than a year | no data | no data | |
Non-Independent Director | 11.6yrs | €27.60k | no data | |
Non-Independent Director | 10.6yrs | €27.60k | no data | |
Independent Director | 10.6yrs | €109.68k | no data | |
Non-Independent Director | 9.6yrs | €27.60k | no data | |
Non-Independent Director | 8.6yrs | €26.40k | no data | |
Non-Independent Director | 7.6yrs | €27.60k | no data | |
Employee Director | 4.2yrs | no data | no data | |
Employee Director | 3.8yrs | no data | no data | |
Non-Independent Director | 3.6yrs | €20.40k | no data | |
Non-Independent Director | 2.6yrs | €25.20k | no data |
7.6yrs
Average Tenure
57yo
Average Age
Experienced Board: GBT's board of directors are considered experienced (7.6 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/17 09:37 |
End of Day Share Price | 2024/12/17 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Guerbet SA is covered by 9 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Laurent Gelebart | BNP Paribas Exane |
Arnaud Cadart | CIC Market Solutions (ESN) |
Robin Leclerc | Degroof Petercam |